David Shaw’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-9,200
Closed -$507K – 5674
2021
Q4
$507K Hold
9,200
– – ﹤0.01% 4394
2021
Q3
$484K Hold
9,200
– – ﹤0.01% 4099
2021
Q2
$634K Buy
+9,200
New +$702K ﹤0.01% 3900

Other funds holding LKFT

David Shaw's LKFT Position: Q3 2026 in Review

David Shaw increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 65% in Q3 2026, buying an estimated $3.66M and bringing the position to 325,660 shares worth $9.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1838.

David Shaw first reported a position in LKFT in Q3 2018 and has held it in 28 quarters since. 95 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.

  • David Shaw held 325,660 shares of Lakefront Biotherapeutics American Depositary Shares worth $9.7M as of Q3 2026.
  • David Shaw bought 127,816 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2026, an estimated $3.66M.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #1838 holding.
  • David Shaw first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2018 and has held it in 28 quarters since.
  • 95 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.